Business Context and Reporting Period
Company: Establishment Labs Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 31, 2024
Reporting Period: Event-based report regarding a specific corporate action on January 31, 2024.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a procedural report regarding a securities offering.
Material Changes
The Company filed a prospectus supplement to its Form S-3 registration statement (Registration No. 333-271418) dated April 24, 2023. This supplement relates to the offering and sale of up to 2,000,000 Common Shares by selling shareholders. The shares consist of:
- 1,101,565 existing Common Shares.
- 898,435 Common Shares issuable upon the exercise of pre-funded warrants.
These shares are held by selling shareholders in connection with a securities purchase agreement dated January 9, 2024.
Guidance, Outlook, and Risks
The filing does not provide management commentary, financial guidance, or an outlook for future performance. No specific risks or contingencies are detailed in this document other than the standard legal opinion regarding the legality of the shares being offered.
Investor Verification Checklist
- Verify the identity of the selling shareholders listed in the Prospectus Supplement.
- Review the securities purchase agreement dated January 9, 2024, for terms related to the pre-funded warrants.
- Confirm the total number of shares outstanding post-offering to assess potential dilution.
- Check the status of the Form S-3 registration statement (No. 333-271418) for any other pending offerings.